Legal

Privacy policy

How OncoSync collects, uses and protects personal data — for visitors to this site and for clinical users of the platform.

Draft — not yet legally reviewed. The structure below is in place, but each section still needs its final wording from counsel before this page is published.

Who we are

OncoSync is operated by OncoSync Health Technologies. This policy explains our role as a data controller for website visitors, and as a data processor acting on instructions from the healthcare organisations that use the platform.

Final wording for this section is pending legal review.

What we collect

Website: contact details you submit through the demo request form, plus aggregate analytics about how pages are used.

Platform: patient records, clinical documents and audit events entered by your organisation. These remain under your organisation's control throughout.

Final wording for this section is pending legal review.

How we use it

Demo requests are used only to arrange and follow up on your session. Clinical data is processed solely to deliver the platform to your organisation.

Final wording for this section is pending legal review.

Lawful basis and consent

Final wording for this section is pending legal review.

Sharing and sub-processors

We publish the current list of sub-processors and give notice before it changes.

Final wording for this section is pending legal review.

Retention and deletion

Final wording for this section is pending legal review.

Where data is stored

Platform data is held in the region your organisation selects at onboarding and is not moved without written instruction.

Final wording for this section is pending legal review.

Your rights

Final wording for this section is pending legal review.

Security

Encryption in transit and at rest, role-based access control, two-factor authentication with enforced password rules, and immutable audit logging.

Final wording for this section is pending legal review.

Contacting us

Requests about this policy should go to our data protection contact.

Final wording for this section is pending legal review.